Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Accentia Biopharmaceuticals Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Accentia Biopharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Accentia Biopharmaceuticals Inc since 2005.
The reporting company's ticker symbol is ABPI. The reporting company's CIK number is 1310094.
The total value of stock buying since 2005 is $8,181,811.
The total value of stock sales since 2005 is $100,000.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2011-12-23||Odonnell Francis E Jr (Executive Chairman)||Sale||500,000||.20||100,000|
|2010-11-24||Odonnell Francis E Jr (CHAIRMAN & CEO)||Buy||225,954||.99||223,694|
|2008-08-12||Odonnell Francis E Jr (Chief Executive Officer)||Buy||11,400||.95||10,830|
|2008-08-11||Odonnell Francis E Jr (Chief Executive Officer)||Buy||13,600||.94||12,838|
|2008-08-08||Odonnell Francis E Jr (Chief Executive Officer)||Buy||50,000||.94||46,800|
|2008-08-06||Odonnell Francis E Jr (Chief Executive Officer)||Buy||25,000||.84||21,000|
|2008-08-05||Odonnell Francis E Jr (Chief Executive Officer)||Buy||25,000||.79||19,750|
|2008-08-04||Odonnell Francis E Jr (Chief Executive Officer)||Buy||25,000||.79||19,750|
|2008-08-01||Odonnell Francis E Jr (Chief Executive Officer)||Buy||25,000||.84||21,000|
|2008-07-31||Odonnell Francis E Jr (Chief Executive Officer)||Buy||25,000||.86||21,500|
|2007-08-14||Odonnell Francis E Jr (Chief Executive Officer)||Buy||875,000||8.87||7,761,249|
Insider trading activities including stock purchases, stock sales, and option exercises of ABPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Accentia Biopharmaceuticals Inc (symbol ABPI, CIK number 1310094) see the Securities and Exchange Commission (SEC) website.